- For Immediate Release:
- October 06, 2020
The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
- Today, the FDA issued guidance with recommendations for vaccine sponsors regarding the scientific data and information that would support issuance of an emergency use authorization (EUA) for investigational vaccines intended to prevent COVID-19.
- Today, FDA launched a new webpage at www.fda.gov/covid19vaccines to highlight new information as it becomes available.
- Testing updates:
- As of today, 271 tests are authorized by FDA under EUAs; these include 214 molecular tests, 52 antibody tests, and 5 antigen tests.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.